ONC

BeOne Medicines
ONC

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$28.62B
EV
$27.10B
Shares Outstanding
121.51M
Beta
0.29

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$330.97
P/E 2025E
209.13x
P/Revenue 2025E
5.61x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About BeOne Medicines Ltd.

gainify
ONC

BeOne Medicines Ltd.

ONC

BeOne Medicines Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company’s commercial stage products include BRUKINSA, a small molecule inhibitor of Br...

Sector

Healthcare

Industry

Medical - Pharmaceuticals

CEO

Oyler, John

Employees

11,000

IPO Date

2016-02-02

Headquarters

Aeschengraben 27, 21st Floor, Basel, Basel-Stadt, 4051, Switzerland

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.